bpc-157 fda approval status warning FDA's Overreach on Compounded Peptides FDA panel votes to ease

Your Questions Answered What is the difference between Methylcobalamin and cyanocobalamin

No human clinical trials have completed as of 2026

In New Hampshire, questions about the legality and safety of TB500 and BPC-157 are common

The peptide chain is not modified

Populations who should not use BPC-157: Pregnant or breastfeeding individuals (no safety data), anyone with a history of cancer (theoretical concern given pro-angiogenic mechanisms), individuals taking anticoagulants (some animal data suggest effects on platelet aggregation pathways), and anyone without access to sterile technique for injection preparation